After graduation, Brooke spent time away from academia and worked two years in the medical field, primarily as a clinical research assistant for a medical device start-up company. She traveled the country working with various physicians and medical staff overseeing one of the largest clinical trials for cervical cancer.
In Fall 2016, Brooke began graduate school as a PhD candidate at The University of Chicago. Soon after, she joined the multidisciplinary team in Savas Tay's laboratory in The University of Chicago's Institute of Molecular Engineering. Brooke's project focused on the development of a microfluidic-based 3D cell culture platform, such as patient-derived cancer organoids, with automated and high-throughput capabilities. She continues to use and develop this integrated platform in hopes to advance the capabilities of research on cancer organoid models, screen and mirror real-life patient chemotherapy treatments and, ultimately, one day facilitate treatment decisions for the development of personalized cancer therapies.